Lidija Beketic-Oreskovic
Lidija Beketic-Oreskovic
Professor of Clinical Oncology, School of Medicine University of Zagreb and UHC Sestre Milosrdnice
Verified email at mef.hr
Title
Cited by
Cited by
Year
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein
BI Sikic, GA Fisher, BL Lum, J Halsey, L Beketic-Oreskovic, G Chen
Cancer chemotherapy and pharmacology 40 (1), S13-S19, 1997
3481997
Klinička onkologija
E Vrdoljak, M Šamija, Z Kusić, M Petković, D Gugić, Z Krajina, M Ban, ...
1602013
Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol)
C Dumontet, GE Duran, KA Steger, L Beketic-Oreskovic, BI Sikic
Cancer research 56 (5), 1091-1097, 1996
1481996
Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdrl gene activation by the cyclosporin PSC 833
L Beketic-Oreskovic, GE Durán, G Chen, C Dumontet, BI Sikic
JNCI: Journal of the National Cancer Institute 87 (21), 1593-1602, 1995
1091995
Tumor markers in breast cancer–evaluation of their clinical usefulness
P Marić, P Ozretić, S Levanat, S Orešković, K Antunac, ...
Collegium antropologicum 35 (1), 241-247, 2011
972011
A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma
S Oreskovic, D Babic, D Kalafatic, D Barisic, L Beketic-Oreskovic
Gynecologic oncology 93 (1), 34-40, 2004
912004
MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells
GK Chen, GE Duran, A Mangili, L Beketic-Oreskovic, BI Sikic
British journal of cancer 83 (7), 892-898, 2000
492000
Fertility after breast cancer treatment
M Kasum, L Beketić-Orešković, PF Peddi, S Orešković, RH Johnson
European Journal of Obstetrics & Gynecology and Reproductive Biology 173, 13-18, 2014
482014
Thrombosis following ovarian hyperstimulation syndrome
M Kasum, D Danolić, S Orešković, D Ježek, L Beketić-Orešković, M Pekez
Gynecological Endocrinology 30 (11), 764-768, 2014
342014
Prognostic significance of carbonic anhydrase IX (CA-IX), endoglin (CD105) and 8-hydroxy-2′-deoxyguanosine (8-OHdG) in breast cancer patients
L Beketic-Oreskovic, P Ozretic, ZN Rabbani, IL Jackson, B Sarcevic, ...
Pathology & Oncology Research 17 (3), 593-603, 2011
282011
Resistance of human larynx carcinoma cells to cisplatin, γ-irradiation and methotrexate does not involve overexpression of c-myc or c-Ki-ras oncogenes
M Osmak, L Beketić-Orešković, M Matulić, J Sorić
Mutation Research Letters 303 (3), 113-120, 1993
251993
Modulation of resistance to cisplatin by amphotericin B and aphidicolin in human larynx carcinoma cells
L Beketic-Oreskovic, M Osmak
Cancer chemotherapy and pharmacology 35 (4), 327-333, 1995
201995
Dopamine agonists in prevention of ovarian hyperstimulation syndrome
M Kasum, H Vrčić, P Stanić, D Ježek, S Orešković, L Beketić-Orešković, ...
Gynecological Endocrinology 30 (12), 845-849, 2014
192014
Assessing the clinical significance of tumor markers in common neoplasms
L Beketic-Oreskovic, P Maric, P Ozretic, D Oreskovic, M Ajdukovic, ...
Front Biosci (Elite Ed) 4 (7), 2558-2578, 2012
162012
Fertility preservation with ovarian stimulation protocols prior to cancer treatment
M Kasum, V Šimunić, S Orešković, L Beketić-Orešković
Gynecological Endocrinology 30 (3), 182-186, 2014
142014
Apoptosis regulator Bcl-2 is an independent prognostic marker for worse overall survival in triple-negative breast cancer patients
P Ozretic, I Alvir, B Sarcevic, Z Vujaskovic, Z Rendic-Miocevic, A Roguljic, ...
The International journal of biological markers 33 (1), 109-115, 2018
132018
Kliničke upute hrvatskoga onkološkog društva za dijagnozu, liječenje i praćenje bolesnica/ka oboljelih od invazivnog raka dojke
R Šeparović, M Ban, T Silovska, L Beketić Orešković, Ž Soldić, P Podolski, ...
Liječnički vjesnik 137 (5-6), 0-0, 2015
12*2015
Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum (II): cross-resistance patterns.
L Beketić-Oresković, M Osmak
Neoplasma 41 (3), 171-176, 1994
111994
Fertility preservation in young women with early-stage breast cancer
P Vuković, M Kasum, J Raguž, N Lonjak, S Bilić Knežević, I Orešković, ...
Acta Clinica Croatica 58 (1.), 147-156, 2019
92019
Immunocytochemical reactivity of a mouse monoclonal antibody CDI 315B raised against human breast carcinoma.
L Beketić-Oresković, B Sarcević, B Malenica, D Novak
Neoplasma 40 (2), 69-74, 1993
91993
The system can't perform the operation now. Try again later.
Articles 1–20